# Usefulness of Non TNF Usage in RA Patients

> **NCT03784261** · PHASE2 · UNKNOWN · sponsor: **Shinshu University** · enrollment: 90 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Drug: "Salirumab"
- **DRUG:** Drug: "Tocilizmab"
- **DRUG:** Drug: "Abatacept"

## Key facts

- **NCT ID:** NCT03784261
- **Lead sponsor:** Shinshu University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-17
- **Primary completion:** 2022-12-16
- **Final completion:** 2024-12-16
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2021-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03784261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03784261, "Usefulness of Non TNF Usage in RA Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03784261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*